Association between prediagnostic IgE levels and risk of glioma

Journal of the National Cancer Institute

Volumn 104, Issue 16, 2012, Pages 1251-1259

  Schwartzbaum, Judith ^a,b   Ding, Bo ^c   Johannesen, Tom Borge ^d   Osnes, Liv T N ^e   Karavodin, Linda ^f   Ahlbom, Anders ^c   Feychting, Maria ^c   Grimsrud, Tom K ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f Karavodin Preclinical Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; GLIOBLASTOMA; GLIOMA; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; TUMOR DIAGNOSIS;

ADULT; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; RESEARCH DESIGN; SEX FACTORS; TIME FACTORS;

EID: 84865463572     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs315     Document Type: Article

References (38)

1. Hamilton RG, MacGlashan DW Jr, Saini SS. IgE antibody-specific activity in human allergic disease. Immunol Res. 2010;47(1-3):273-284.
2. Milovanovic M, Drozdenko G, Weise C, Babina M, Worm M. Interleukin-17A promotes IgE production in human B cells. J Invest Dermatol. 2010;130(11):2621-2628.
3. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10(4):225-235.
4. Matricardi PM, Bockelbrink A, Gruber C, Keil T, Hamelmann E, Wahn U, et al. Longitudinal trends of total and allergen-specific IgE throughout childhood. Allergy. 2009;64(7):1093-1098.
5. Engkilde K, Thyssen JP, Menne T, Johansen JD. Association between cancer and contact allergy: a linkage study. BMJ Open. 2011;1(1):e000084.
6. Christensen LH, Holm J, Lund G, Riise E, Lund K. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol. 2008;122(2):298-304.
7. Hamilton RG. Provocation tests with objective measures remain more diagnostic than surrogate immunoglobulin E antibody measures of sensitization. Clin Exp Allergy. 2011;41(8):1048-1049.
8. Turner MC. Epidemiology: allergy history, IgE, and cancer [published online ahead of print December 20, 2011]. Cancer Immunol Immunother. doi:10.1007/s00262-011-1180-6.
9. Sherman PW, Holland E, Sherman JS. Allergies: their role in cancer prevention. Q Rev Biol. 2008;83(4):339-362.
10. Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, et al. Allergy and risk of glioma: a meta-analysis. Eur J Neurol. 2011;18(3):387-395.
11. Davis FG, Al-Alem U. Allergies and adult gliomas: cohort results strengthen evidence for a causal association. J Natl Cancer Inst. 2011;103(21):1562-1563.
12. Schwartzbaum J, Karavodin L, Kapur N, Fisher JL. Unexpected benefits of allergies and cigarette smoking: two examples of paradox in neuroepidemiology In: Kapur N, ed. The Paradoxical Brain. Cambridge, England: Cambridge University Press; 2011:261-273.
13. Schlehofer B, Siegmund B, Linseisen J, Schuz J, Rohrmann S, Becker S, et al. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011;66(11):1434-1441.
14. Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011;103(21):1588-1595.
15. Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y, et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci USA. 2012; 109(8):3041-3046.
16. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. The JANUS serum bank. Sci Total Environ. 1993;139-140:527-535.
17. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. Experiences of the Janus Serum Bank in Norway. Environ Health Perspect. 1995;103(suppl 3):85-88.
18. Langseth H, Gislefoss R, Martinsen JI, Stornes A, Lauritzen M, Andersen A, et al. The Janus Serum Bank-From Sample Collection to Cancer Research. Oslo: Cancer Registry of Norway; 2009.
19. Helgesson G, Dillner J, Carlson J, Bartram CR, Hansson MG. Ethical framework for previously collected biobank samples. Nat Biotechnol. 2007;25(9):973-976. (Pubitemid 47517629)
20. CBTRUS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2011.
21. Kerkhof M, Droste JH, de Monchy JG, Schouten JP, Rijcken B. Distribution of total serum IgE and specific IgE to common aeroallergens by sex and age, and their relationship to each other in a random sample of the Dutch general population aged 20-70 years. Dutch ECRHS Group, European Community Respiratory Health Study. Allergy. 1996;51(11):770-776. (Pubitemid 26384209)
22. Chapman MD, Pomes A, Breiteneder H, Ferreira F. Nomenclature and structural biology of allergens. J Allergy Clin Immunol. 2007;119(2):414-420.
23. Greenland S. Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med. 1983;2(2):243-251. (Pubitemid 13020136)
24. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004;13(9):635-638. (Pubitemid 39279773)
25. Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521-574. (Pubitemid 47236336)
26. Jensen-Jarolim E, Untersmayr E. Gender-medicine aspects in allergology. Allergy. 2008;63(5):610-615. (Pubitemid 351490402)
27. Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, et al. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2562-2569.
28. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445-1453. (Pubitemid 47339290)
29. Henderson CE, Ownby D, Klebanoff M, Levine RJ. Stability of immunoglobulin E (IgE) in stored obstetric sera. J Immunol Methods. 1998;213(1):99-101. (Pubitemid 28376598)
30. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med. 2009;47(5):596-603.
31. Paganelli R, Ansotegui IJ, Sastre J, Lange CE, Roovers MH, de Groot H, et al. Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy. 1998;53(8):763-768. (Pubitemid 28374757)
32. Blair A, Stewart P, Lubin JH, Forastiere F. Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med. 2007;50(3):199-207. (Pubitemid 46363811)
33. Burton OT, Oettgen HC. Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev. 2011;242(1):128-143.
34. Hakim-Rad K, Metz M, Maurer M. Mast cells: makers and breakers of allergic inflammation. Curr Opin Allergy Clin Immunol. 2009;9(5):427-430.
35. Barnes PJ. Corticosteroids, IgE, and atopy. J Clin Invest. 2001;107(3):265-266.
36. Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009;125(3):680-687.
37. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, et al. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy. 2008;63(10):1255-1266. PMCID: 2999743.
38. Riemer AB, Untersmayr E, Knittelfelder R, Duschl A, Pehamberger H, Zielinski CC, et al. Active induction of tumor-specific IgE antibodies by oral mimotope vaccinations. Cancer Res. 2007;67(7):3406-3411. (Pubitemid 46724881)